Open AccessAdjuvant chemoradiotherapy vs adjuvant chemotherapy in locally advanced Siewert type II/III adenocarcinoma of gastroesophageal junction after D2/R0 resection
Author(s) -
Wenzhe Kang,
Jiachen Shi,
Bingzhi Wang,
Jianping Xiong,
Xinxin Shao,
Haitao Hu,
Jing Jin,
Yantao Tian
Publication year - 2022
Publication title -
world journal of gastrointestinal oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.924
H-Index - 26
ISSN - 1948-5204
DOI - 10.4251/wjgo.v14.i8.1540
Subject(s) - medicine , chemoradiotherapy , adenocarcinoma , adjuvant , proportional hazards model , gastroenterology , adjuvant chemotherapy , chemotherapy , cancer , breast cancer
For Siewert type II/III adenocarcinoma of gastroesophageal junction (AGE), the efficacy of adjuvant chemoradiotherapy (CRT) after D2/R0 resection remains uncertain.